Pharmacoeconomy of Diabetes Mellitus and its Implications for Organization and Quality of the Care in the Czech Republic

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10287525" target="_blank" >RIV/00216208:11110/14:10287525 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/14:10287525 RIV/00064203:_____/14:10287525 RIV/00064165:_____/14:10287525

Výsledek na webu

<a href="http://www.ejbi.org/img/ejbi/2014/2/Horak_en.pdf" target="_blank" >http://www.ejbi.org/img/ejbi/2014/2/Horak_en.pdf</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Pharmacoeconomy of Diabetes Mellitus and its Implications for Organization and Quality of the Care in the Czech Republic

Popis výsledku v původním jazyce

Introduction: Organization of the care is important factor for success, cost effectiveness and quality of the care for large scale chronic diseases such as diabetes mellitus. Valid data are needed for decision support. Aim: To calculate real prevalence of diabetes in the population from incomplete data sources originally created for billing to the insurance company, to establish how these patients are treated and collect markers of quality of the care. Methods: In data sources diabetic patients were identified by combining diagnoses from coded procedures with data about medical prescription and procedures directly linked to diabetes. Results: 6% increase in real incidence rate of diabetes mellitus patients since 2002 was observed as well as 23% (2003-2009) decrease in mortality rate (50% decrease between 1980 to 2009). Data also show not only higher average expenses for treatment of patients with diabetes mellitus compared to average expenses incurred for treatments of all other diagno

Název v anglickém jazyce

Pharmacoeconomy of Diabetes Mellitus and its Implications for Organization and Quality of the Care in the Czech Republic

Popis výsledku anglicky

Introduction: Organization of the care is important factor for success, cost effectiveness and quality of the care for large scale chronic diseases such as diabetes mellitus. Valid data are needed for decision support. Aim: To calculate real prevalence of diabetes in the population from incomplete data sources originally created for billing to the insurance company, to establish how these patients are treated and collect markers of quality of the care. Methods: In data sources diabetic patients were identified by combining diagnoses from coded procedures with data about medical prescription and procedures directly linked to diabetes. Results: 6% increase in real incidence rate of diabetes mellitus patients since 2002 was observed as well as 23% (2003-2009) decrease in mortality rate (50% decrease between 1980 to 2009). Data also show not only higher average expenses for treatment of patients with diabetes mellitus compared to average expenses incurred for treatments of all other diagno

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FB - Endokrinologie, diabetologie, metabolismus, výživa

OECD FORD obor

—

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

European Journal for Biomedical Informatics

ISSN

1801-5603

e-ISSN

—

Svazek periodika

10

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

6

Strana od-do

2-7

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—